Subscribe to receive latest news/articles
If you would like to automatically receive newletters and alerts from the BioMedPress, please fill in the form below
Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).
http://www.wame.org/recommendations-on-publication-ethics-policie
1. The Progress in STEM CELL has the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole, and to stop accepting any advertisement previously accepted. Ads are subject to review by the editor and others at the Progress in STEM CELL. In no case shall separate agreements with the Progress in STEM CELL or its subsidiaries supersede this policy.
2. Advertising for the following categories is prohibited:
3. Advertisements new to Progress in STEM CELL may require pre-approval before they can appear. Refer to the individual publication ad policies or call your advertising representative for more information.
4. Advertisers may be required to submit supporting documentation to substantiate claims. For products not regulated by the FDA or other government agency, technical and/or scientific documentation may be required.
5. Ads for products not approved by the FDA that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.â€
6. While the Progress in STEM CELL welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such.
7. In Progress in STEM CELL professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the ad is prohibited.
8. Advertisements may not imply endorsement by the Progress in STEM CELL or its publications/web sites except as may be provided for under a separate agreement—in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
9. The full rules for any market research or promotion associated with an advertisement must be displayed in the ad or available via a prominent link.
10. The following online advertising formats are prohibited:
Progress in STEM CELL’s published advertising policies are not exhaustive and are subject to change at any time without notice.
ISSN: 2199-4633
DOI Prefix: 10.15419 (from Vol3), 10.7603 (for Vol 1 & 2)
Indexed: EMBASE (Elsevier), Google Scholar, The Open Archives Initiative (OAI), OCLC WorldCat, BASE, ScopeMed
Under evaluation: Web of Science, Scopus
In PubMed/Pubmed Central: Selected citations only
Phuc Van Pham
University of Science, Vietnam National University, Ho Chi Minh city, Vietnam
Ngoc Kim Phan
University of Science, Vietnam National University, Ho Chi Minh city, Vietnam
Lili Hami
University of Science, Vietnam National University, Ho Chi Minh city, Vietnam
Contact:
Editor-in-Chief: pvphuc@bmrat.org
Support Team: support@bmrat.org
Managing Editor: managingeditor@bmrat.org
If you would like to automatically receive newletters and alerts from the BioMedPress, please fill in the form below
ISSN: 2199-4633
Copyright © 2014-2021 Biomedpress. This work is licensed under a Creative Commons Attribution 4.0 License. A partner of Crossref.